Modulation of Sleep Physiology by Nocturnal Deep Brain Stimulation Amplitude in Parkinson’s Disease

The First Light: Efficacy and Safety of a Multi-dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor Two Agonist for the Treatment of Narcolepsy Type One